Abstract
As an alternative to DNA-based vaccines, messenger RNA (mRNA)-based vaccines present additional safety features: no persistence, no integration in the genome, no induction of autoantibodies. Moreover, mRNA which are generated by in vitro transcription, are easy to produce in large amounts and very high purity. This feature facilitates the good manufacturing practices process and guaranties batch-to-batch reproducibility. Vaccination can be achieved by several delivery methods including direct injection of naked mRNA, injection of mRNA encapsulated in liposomes Gene Gun delivery of mRNA loaded on gold beads or in vitro transfection of the mRNA in cells followed by re-injection of the cells into the patients. Two of these technologies are being evaluated in human clinical trials: (1) in vitro mRNA-transfection of dendritic cells to be adoptively transferred and (2) direct injection of globin-stabilized mRNA. This chapter describes the production of mRNA and the preparation of the two types of mRNA-based vaccines tested in humans.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pascolo, S. (2004) Messenger RNA-based vaccines. Expert. Opin. Biol. Ther. 4, 1285–1294.
Heiser, A., Coleman, D., Dannull, J., et al. (2002) Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors. J. Clin. Invest. 109, 409–417.
Morse, M. A., Nair, S. K., Mosca, P. J., et al. (2003) Immunotherapy with autologous, human dendritic cells transfected with carcinoembryonic antigen mRNA. Cancer Invest. 21, 341–349.
Su, Z., Dannull, J., Heiser, A., et al. (2003) Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells. Cancer Res. 63, 2127–2133.
Hoerr, I., Obst, R., Rammensee, H. G., and Jung, G. (2000) In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies. Eur. J. Immunol. 30, 1–7.
Malek, J. A., Shatsman, S. Y., Akinretoye, B. A., and Gill, J. E. (2000) Degradation of persistent RNA in RNase-containing, high-throughput alkaline lysis DNA preparations. Biotechniques 29, 250–252.
Azarani, A. and Hecker, K. H. (2001) RNA analysis by ion-pair reversed-phase high performance liquid chromatography. Nucleic Acids Res. 29, E7.
Sallusto, F. and Lanzavecchia, A. (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179, 1109–1118.
Ponsaerts, P., Van Tendeloo, V. F., and Berneman, Z. N. (2003) Cancer immunotherapy using RNA-loaded dendritic cells. Clin. Exp. Immunol. 134, 378–384.
Nair, S. K., Boczkowski, D., Morse, M., Cumming, R. I., Lyerly, H. K., and Gilboa, E. (1998) Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA. Nat. Biotechnol. 16, 364–369.
Schuler-Thurner, B., Schultz, E. S., Berger, T. G., et al. (2002) Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells. J. Exp. Med. 195, 1279–1288.
Wolff, J. A., Malone, R. W., Williams, P., et al. (1990) Direct gene transfer into mouse muscle in vivo. Science 247, 1465–1468.
Carralot, J. P., Probst, J., Hoerr, I., et al. (2004) Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines. Cell Mol. Life Sci. 61, 2418–2424.
Kiyama, R. and Oishi, M. (1996) In vitro transcription of a poly(dA) x poly(dT)-containing sequence is inhibited by interaction between the template and its transcripts. Nucleic Acids Res. 24, 4577–4583.
Grabczyk, E. and Usdin, K. (2000) The GAA*TTC triplet repeat expanded in Friedreich’s ataxia impedes transcription elongation by T7 RNA polymerase in a length and supercoil dependent manner. Nucleic Acids Res. 28, 2815–2822.
Jarrossay, D., Napolitani, G., Colonna, M., Sallusto, F., and Lanzavecchia, A. (2001) Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur. J. Immunol. 31, 3388–3393.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc.
About this protocol
Cite this protocol
Pascolo, S. (2006). Vaccination With Messenger RNA. In: Saltzman, W.M., Shen, H., Brandsma, J.L. (eds) DNA Vaccines. Methods in Molecular Medicine™, vol 127. Humana Press. https://doi.org/10.1385/1-59745-168-1:23
Download citation
DOI: https://doi.org/10.1385/1-59745-168-1:23
Publisher Name: Humana Press
Print ISBN: 978-1-58829-484-5
Online ISBN: 978-1-59745-168-0
eBook Packages: Springer Protocols